Practice
Featured experience
Novo Nordisk acquisition of certain Catalent sites from Novo Holdings
We are advising Novo Nordisk on the acquisition
Reddit $748 million IPO
The shares are listed on the New York Stock Exchange
Grayscale Bitcoin Trust approved as world’s largest bitcoin ETF
We advised Grayscale in the yearslong effort to secure SEC approval for the NYSE Arca listing
Harvest Partners $5.34 billion fundraise for its ninth flagship PE fund
We advised Harvest Partners on the fundraise
Ascentage Pharma $126.4 million IPO
The IPO is the first life sciences U.S. IPO of 2025 and the first life sciences company listed on the HKEX to complete a U.S…
Ascentage Pharma $126.4 million IPO
The IPO is the first life sciences U.S. IPO of 2025 and the first life sciences company listed on the HKEX to complete a U.S…
Ascentage Pharma $126.4 million IPO
The IPO is the first life sciences U.S. IPO of 2025 and the first life sciences company listed on the HKEX to complete a U.S…
PAR Technology $115 million convertible senior notes offering
The notes are due 2030
PAR Technology $115 million convertible senior notes offering
The notes are due 2030
PAR Technology $115 million convertible senior notes offering
The notes are due 2030
Central American Bank for Economic Integration $1.5 billion notes
The notes are due 2028
Central American Bank for Economic Integration $1.5 billion notes
The notes are due 2028
Emera exchange offer
We advised Emera on its exchange offer
Emerson $7.2 billion acquisition of remaining outstanding shares of AspenTech
We are advising Emerson on its acquisition